Age Verification Required

Imperial Peptides

By entering this site you confirm that:

  • You are 18 years of age or older
  • All products are for research purposes only — not for human consumption
  • You are a qualified researcher, scientist, or licensed professional
  • You understand these compounds are not approved by the FDA for human use

This confirmation is stored locally and will not be requested again on this device.

We are currently accepting pre-orders to ensure we have the right products in stock to best serve our customers. If you are interested in a product we do not currently carry, please do not hesitate to reach out — we welcome all product requests.
Back to Research Library
Weight Loss

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist

A novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist.

Overview

Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. It is a 39-amino acid synthetic peptide that activates both incretin hormone receptors simultaneously. Research has investigated its effects on glycemic control, body weight, and metabolic parameters.

Research Information

Research on tirzepatide has focused on its unique dual-agonist mechanism. Studies suggest simultaneous activation of both GIP and GLP-1 receptors may produce additive or synergistic effects on insulin secretion, glucagon suppression, and appetite regulation.

Research Dosage Reference

Research protocols begin with lower doses and escalate over time. Standard vials contain 5mg lyophilized powder. All dosing information is for research reference only.

Ready to Order?

Purchase high-purity Tirzepatide for your research.

Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.